Investor Relations

Stock price graph
     

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

PDF 2013 Annual Report [ 4.4 MB]

Recent Releases

Oct 29, 2014
Exact Sciences Announces Meriter-UnityPoint Health Now Offering Cologuard®

Oct 27, 2014
Exact Sciences Reports Third-Quarter 2014 Financial Results

Oct 22, 2014
Exact Sciences Announces MDVIP As The First Network of Personalized Healthcare Physicians To Offer Cologuard, A New Noninvasive Stool-Based DNA Test For Colon Cancer

View all releases »

Stock Quote

Ticker:
EXAS
Exchange:
NASDAQ
Price:
24.07
Change:
- 0.74
Volume:
1,734,600
4:00 PM ET on Oct 31, 2014
Delayed at least 20 minutes.
Provided by eSignal.

IR Search